Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/98469
Title: Molecular epidemiology of nontypeable haemophilus influenzae causing community-acquired pneumonia in adults
Author: Puig Pitarch, Carmen
Calatayud, Laura
Martí Martí, Sara
Tubau, Fe
Garcia Vidal, Carolina
Carratalà, Jordi
Liñares Louzao, Josefina
Ardanuy Tisaire, María Carmen
Keywords: Epidemiologia molecular
Bacteris patògens
Pneumònia adquirida a la comunitat
Malalties de l'aparell respiratori
Molecular epidemiology
Pathogenic bacteria
Community-acquired pneumonia
Respiratory diseases
Issue Date: 13-Dec-2013
Publisher: Public Library of Science (PLoS)
Abstract: Nontypeable Haemophilus influenzae (NTHi) is an opportunistic pathogen which causes a variety of respiratory infections. The objectives of the study were to determine its antimicrobial susceptibility, to characterize the b-lactam resistance, and to establish a genetic characterization of NTHi isolates. Ninety-five NTHi isolates were analyzed by pulsed field gel electrophoresis (PFGE) and multi locus sequence typing (MLST). Antimicrobial susceptibility was determined by microdilution, and the ftsI gene (encoding penicillin-binding protein 3, PBP3) was PCR amplified and sequenced. Thirty (31.6%) isolates were non-susceptible to ampicillin (MIC$2 mg/L), with 10 of them producing b-lactamase type TEM-1 as a resistance mechanism. After ftsI sequencing, 39 (41.1%) isolates showed amino acid substitutions in PBP3, with Asn526->Lys being the most common (69.2%). Eighty-four patients were successfully treated with amoxicillin/clavulanic acid, ceftriaxone and levofloxacin. Eight patients died due either to aspiration or complication of their comorbidities. In conclusion, NTHi causing CAP in adults shows high genetic diversity and is associated with a high rate of reduced susceptibility to ampicillin due to alterations in PBP3. The analysis of treatment and outcomes demonstrated that NTHi strains with mutations in the ftsI gene could be successfully treated with ceftriaxone or fluoroquinolones.
Note: Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0082515
It is part of: PLoS One, 2013, vol. 8, num. 12, p. e82515
Related resource: http://dx.doi.org/10.1371/journal.pone.0082515
URI: http://hdl.handle.net/2445/98469
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
628558.pdf467.05 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons